CareDx to Host Symposium at CEoT Featuring the Latest Multim

SOUTH SAN FRANCISCO, Calif., April 06, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare

Related Keywords

California , United States , South San Francisco , Sasha King , Deborah Jo Levine , Amishi Desai , Caredx Allosure , Cian Cooney , Neeraj Singh , Abdolreza Haririan , Kidney International , Langone Health , Loyola University Introduction To Multimodality Kidney Surveillance , Company Caredx Inc , University Of Maryland School Medicine Kidneycare , Nasdaq , Johnc Mcdonald Regional Transplant Center , Health Sciences Center , Vaccination Booster Administration , University Of Texas , University Of Maryland Medical Center , Caredx Inc , Transplant Company , Multimodality Approach , American Society , Transplantation Cutting Edge , Kidney Transplant Recipients Following , Booster Administration , Allosure Kidney , Greg Seeto , Predictive Power , Associate Professor , Medical Director , Pancreas Transplantation , Division Chief , Transplant Nephrology , Loyola University Introduction , Multimodality Kidney Surveillance , Maryland Medical Center , Maryland School , Medicine Kidneycare , Improved Precision , Donald Regional Transplant Center , Sciences Center , Shreveport The Entire Picture , Critical Care Medicine , Transplant Company Caredx , Looking Statements This , Annual Report , Sasha King Chief Marketing Officer , Relations Ian Cooney , Money , Ational ,